As the adoption of AI continues to accelerate, several challenges remain. To overcome these challenges, organizations need to reach digital maturity. That means developing robust governance and data maintenance processes. Moreover, they must implement modern software disciplines like Agile and DevOps. In addition, the “last mile” problem is a significant hurdle from a scale perspective. […]
Read More
Future studies will examine potential markers of tumors, including a protein called MRE11, which plays a vital role in the cellular response to DNA damage induced by radiation. These findings could help doctors design strategies that preserve the bladder after radiation therapy. This will be especially useful for patients because removing the bladder can have […]
Read More
Multidisciplinary treatment is evolving from a series of isolated procedures to an integrated approach that combines radiation oncology, medical oncology, and allied health services. This interdisciplinary approach considers treatment options, establishes a treatment plan, and provides supportive care. As a result, radiation oncology centers are gaining more expertise in particular techniques and malignancies. They are […]
Read More
The main difference between real-time and off-line image-guided adaptive radiotherapy is that the latter relies on software to control radiation therapy. For example, real-time image-guided adaptive radiotherapy will require a more sophisticated model that will have stopping rules to pause treatment when the deviation from the treatment plan reaches a certain threshold. Aside from the […]
Read MoreAccording to Dattoli Cancer Center, traditional treatment planning involves many manual processes. The optimal dose distribution must be determined for every patient. This optimal dose distribution never exists a priori, and planners must negotiate multiple competing parameters in a trial-and-error process. Optimization processes iteratively optimize clinical and dosimetric objectives. Dattoli Cancer Center explains Method […]
Read MoreTestosterone: Friend or Foe? MICHAEL DATTOLI, MD & GINYA CARNAHAN, APR, CRPC Dattoli Cancer Center Perhaps one of the most controversial subjects in the prostate cancer world is the role of testosterone – its influence on the development of prostate cancer, its impact on current tumor growth, and more recently its possible ability to slow […]
Read More